RESEARCH PROGRAMS:

MMRF CoMMpassSM Study

In The News


     

Press Releases

 

The Multiple Myeloma Research Foundation (MMRF) and the U.S. Department of Veterans Affairs (VA) Create Unprecedented Private/Public Partnership to Advance the Development of Personalized Medicine - November 26, 2012

The Multiple Myeloma Research Foundation (MMRF) Announces Collaboration with US Oncology Research for Landmark Clinical Study - June 13, 2012

Multiple Myeloma Research Consortium (MMRC) and Synta Pharmaceuticals Announce First Patient in Clinical Trial in Multiple Myeloma - April 10, 2012

The Multiple Myeloma Research Foundation (MMRF) Presents Study Design for Landmark Trial Focused on Genomic Analysis at the AACR Annual Meeting - April 3, 2012

The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study - April 2, 2012

The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study - December 19, 2011

Multiple Myeloma Research Foundation (MMRF) and Onyx Pharmaceuticals Announce Multi-Year Collaboration to Accelerate Personalized Medicine Approaches for Multiple Myeloma - December 14, 2011

Multiple Myeloma Research Foundation (MMRF) Announces Millennium as First Industry Partner in Innovative Collaboration to Advance Personalized Medicine for Multiple Myeloma - September 29, 2011

Multiple Myeloma Research Foundation (MMRF) Announces First Patient Enrolled in Landmark 1000-Patient Study, with Four World-Class Cancer Centers as First Clinical Sites - September 20, 2011

 

How do I find out more?

Those who are interested in learning more about the MMRF CoMMpass study and whether they qualify, should call 866-603-6628 or email patientnavigator@themmrf.org.

 
It only takes a
phone call.

Contact MMRF today
at 800-603-6628 to learn more about participating in the CoMMpass study.
Call Now
Find a
CoMMpass Location

People who are recently diagnosed with Multiple Myeloma who are not taking medications are needed.
Find a Site